PMID- 32321168 OWN - NLM STAT- MEDLINE DCOM- 20201113 LR - 20230216 IS - 1541-6100 (Electronic) IS - 0022-3166 (Linking) VI - 150 IP - 7 DP - 2020 Jul 1 TI - Consumption of the Artificial Sweetener Acesulfame Potassium throughout Pregnancy Induces Glucose Intolerance and Adipose Tissue Dysfunction in Mice. PG - 1773-1781 LID - 10.1093/jn/nxaa106 [doi] AB - BACKGROUND: Sugar-sweetened beverage consumption is associated with metabolic dysfunction. Artificially sweetened beverages (ASBs) are often promoted as an alternative. However, evidence for the safety of ASB consumption during pregnancy is lacking. OBJECTIVES: The effects of sugar-sweetened beverage and ASB consumption during pregnancy in mice were examined, and we hypothesized that both sugar-sweetened beverages and ASBs would impair maternal metabolic function. METHODS: Pregnant female C57BL/6J mice received control drinking water (CD), high-fructose corn syrup (Fr; 20% kcal intake; 335 mM), or the artificial sweetener acesulfame potassium (AS; 12.5 mM) in their drinking water, from gestational day (GD) 0.5 (n = 8/group). Body weights and food and water intakes were assessed every second day, an oral-glucose-tolerance test (OGTT) was performed at GD 16.5, and mice were culled at GD 18.5. RT-PCR was carried out on adipose tissue, liver, and gut. Adipose tissue morphology was assessed using histological methods. In a separate cohort of animals, pregnancy length was assessed. Repeated-measures ANOVA was performed for the OGTT and weight gain data. All other data were analyzed by 1-way ANOVA. RESULTS: Fr and AS significantly impaired glucose tolerance, as demonstrated by OGTT (21% and 24% increase in AUC, respectively; P = 0.0006). Fr and AS reduced expression of insulin receptor (39.5% and 33% reduction, respectively; P = 0.02) and peroxisome proliferator-activated receptor gamma (45.2% and 47%, respectively; P = 0.039), whereas Fr alone reduced expression of protein kinase B (36.9% reduction; P = 0.048) and resulted in an increase in adipocyte size and leptin concentrations (40% increase; P = 0.03). AS, but not Fr, reduced male fetal weight (16.5% reduction; P = 0.04) and female fetal fasting blood glucose concentration at cull (20% reduction; P = 0.02) compared with CD. AS significantly reduced the length of pregnancy compared with the CD and Fr groups (1.25 d shorter; P = 0.02). CONCLUSIONS: Fr and AS consumption were associated with maternal metabolic dysfunction in mice. AS was also associated with reduced fetal growth and fetal hypoglycemia. Therefore, ASBs may not be a beneficial alternative to sugar-sweetened beverages during pregnancy. CI - Copyright (c) The Author(s) on behalf of the American Society for Nutrition 2020. FAU - Plows, Jasmine F AU - Plows JF AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. AD - Children's Hospital Los Angeles, The Saban Research Institute, Los Angeles, CA, USA. FAU - Morton-Jones, Jacob AU - Morton-Jones J AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. FAU - Bridge-Comer, Pania E AU - Bridge-Comer PE AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. FAU - Ponnampalam, Anna AU - Ponnampalam A AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. AD - Department of Physiology, University of Auckland, Auckland, New Zealand. AD - Department of Obstetrics and Gynecology, University of Auckland, Auckland, New Zealand. FAU - Stanley, Joanna L AU - Stanley JL AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. FAU - Vickers, Mark H AU - Vickers MH AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. FAU - Reynolds, Clare M AU - Reynolds CM AD - The Liggins Institute, University of Auckland, Auckland, New Zealand. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Nutr JT - The Journal of nutrition JID - 0404243 RN - 0 (Blood Glucose) RN - 0 (Sweetening Agents) RN - 0 (Thiazines) RN - MA3UYZ6K1H (acetosulfame) SB - IM MH - Adipocytes/drug effects MH - Adipose Tissue/*drug effects MH - Animals MH - Blood Glucose/drug effects MH - Diet MH - Female MH - Fetus/drug effects MH - Gastrointestinal Tract/drug effects/metabolism MH - Gene Expression Regulation/drug effects MH - Glucose Intolerance/*chemically induced MH - Liver/drug effects/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - *Sweetening Agents MH - Thiazines/administration & dosage/*adverse effects OTO - NOTNLM OT - adipose tissue OT - fructose OT - glucose intolerance OT - non-nutritive sweeteners OT - pregnancy EDAT- 2020/04/23 06:00 MHDA- 2020/11/18 06:00 CRDT- 2020/04/23 06:00 PHST- 2020/01/14 00:00 [received] PHST- 2020/02/20 00:00 [revised] PHST- 2020/03/26 00:00 [accepted] PHST- 2020/04/23 06:00 [pubmed] PHST- 2020/11/18 06:00 [medline] PHST- 2020/04/23 06:00 [entrez] AID - S0022-3166(22)02238-6 [pii] AID - 10.1093/jn/nxaa106 [doi] PST - ppublish SO - J Nutr. 2020 Jul 1;150(7):1773-1781. doi: 10.1093/jn/nxaa106.